Skip to content
🌐 Global🇮🇳 India📍 Asia-Pacific📍 Bihar📍 Delhi-NCR📍 East India📍 Europe📍 Gujarat📍 Karnataka📍 Kerala📍 Madhya Pradesh📍 Maharashtra📍 Middle East📍 North India📍 Northeast India📍 Punjab📍 Rajasthan📍 South India📍 Tamil Nadu📍 Telangana📍 United Kingdom📍 United States📍 Uttar Pradesh📍 West Bengal📍 West India
LIVE
Home / Business
Business

Sun Pharma inks pact with LIB Therapeutics to sell LDL-C drug

Lerodalcibep is approved in the EU under the brand name Lyrokaul. In the U.S, it is FDA-approved under the brand name Lerochol

The Hindu BusinessSeptember 28, 20261 min read
Share this story
Sun Pharma inks pact with LIB Therapeutics to sell LDL-C drug

Lerodalcibep is approved in the EU under the brand name Lyrokaul. In the U.S, it is FDA-approved under the brand name Lerochol

📡 Verified Wire Agency Verified Resource & Provenance
✉
The Next Brief
Get the day's most important stories in one email
AI-curated morning digest. No noise. Unsubscribe anytime.

Comments 0

Advertisement

Related stories

Most read

  1. 1Crusoe abandons $1.25B plan to use Boom turbines at AI data centersBusiness
  2. 2Venezuela Oil Output Could Hit 1.8 Million Bpd By 2030, Rystad SaysFinance
  3. 3Colombia extradites leader of armed group to US in shift towards WashingtonWorld
  4. 4Ultrathin materials could make quantum light circuits programmableScience
  5. 5Sachivalayam staff plan to organise ‘Chalo Vijayawada’ on September 27Politics